SINGAPORE — Four months after the anaesthetic agent etomidate was classified as a Class C drug under Singapore’s Misuse of Drugs Act, a new challenge is emerging as former users of illicit “Kpods” turn to alternative substances, including prescription medications that remain outside the strictest drug controls. 

Kpods — vape pods adulterated with etomidate that gained popularity among some youth — were driven further underground after authorities tightened enforcement last September, treating etomidate possession and distribution as serious drug offences. The reclassification aimed to discourage use by imposing heavier penalties and mandatory rehabilitation for offenders. 

However, addiction management professionals have observed a shift in habits among those previously dependent on Kpods. With etomidate now subject to harsher punishment, some former users are experimenting with readily available prescription drugs or other substances perceived to be legal and easier to obtain. 

Those affected describe a cycle of seeking substances that fill the void left by Kpods, with some patients reporting use of pills that are not regulated as controlled drugs. Because these medications are prescribed legitimately for medical conditions, their misuse can evade immediate detection and enforcement. 

Health experts caution that turning to such substances carries its own risks to physical and mental well-being, even if legal frameworks have yet to catch up with changing patterns of misuse. The shift highlights complexities in addressing substance dependence in an environment of evolving drug trends and regulatory measures. 

While the crackdown on Kpods has reduced the visibility of etomidate-laced products, the trend of substituting other drugs raises concerns for treatment providers about emerging forms of dependency that may require tailored intervention strategies.